There are eye drops – and there are eye drops. Some eye drops are called “artificial tears” and some eye drops are called “redness relievers.” Whatever you call them, in an age of global warming, drying, drought, pollution, dehydrating “techno” environments and a rapidly growing epidemic of dry eye disease, worldwide sales of eye drops are booming.
But are eye drops the very best the pharmaceutical community has to offer to control the dry eye epidemic?
First of all, it is important to understand that untreated dry eye can lead to discomfort, blurred vision, headache, fatigue, loss of energy, depression, corneal ulceration, glaucoma, cataracts, eye cancer and blindness. Also, while there may be considerable room for improvement in the air quality of the United States and Europe, our air is fantastic compared to China, India, South Korea, Argentina, Brazil, Mexico and Nigeria. Nevertheless, in the U.S., dry eye symptoms have become the number one reason for eye doctor visits and over 100 U.S. cities are identified as “dry eye hot spots.” Globally, someone goes blind every five seconds, much of it related to air quality, water availability and water quality.